← Back to Search

Selective Serotonin Reuptake Inhibitor

SSRI or cognitive behavioral therapy for Obsessive-Compulsive Disorder

Phase 4
Waitlist Available
Led By Roseli G Shavitt, MD, PhD
Research Sponsored by University of Sao Paulo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No CBT/EXRP focused on OCD within the past 6 weeks
Principal DSM-5 diagnosis of OCD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is looking at people with OCD who have participated in a global study investigating brain signatures of OCD, funded by the National Institutes of Mental Health. The trial will assess clinical, neurocognitive and neuroimaging data, and participants who are willing to receive evidence-based treatments for OCD will be treated and assessed for treatment response status periodically, with a final assessment after 1 year of naturalistic follow-up.

Eligible Conditions
  • Obsessive-Compulsive Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have not received cognitive-behavioral therapy or exposure and response prevention therapy for obsessive-compulsive disorder in the past six weeks.
Select...
You have been diagnosed with OCD according to the DSM-5 guidelines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
level of improvement
response status

Trial Design

1Treatment groups
Experimental Treatment
Group I: SSRI or cognitive behavioral therapyExperimental Treatment1 Intervention
selective serotonin reuptake inhibitors (fluoxetine, sertraline, citalopram, escitalopram, paroxetine or fluvoxamine) or cognitive-behavioral therapy, depending on availability and patient preference
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
selective serotonin reuptake inhibitor
2018
Completed Phase 4
~250

Find a Location

Who is running the clinical trial?

University of Sao PauloLead Sponsor
1,043 Previous Clinical Trials
254,227 Total Patients Enrolled
6 Trials studying Obsessive-Compulsive Disorder
386 Patients Enrolled for Obsessive-Compulsive Disorder
University of StellenboschOTHER
94 Previous Clinical Trials
113,171 Total Patients Enrolled
1 Trials studying Obsessive-Compulsive Disorder
9 Patients Enrolled for Obsessive-Compulsive Disorder
Columbia UniversityOTHER
1,424 Previous Clinical Trials
2,472,777 Total Patients Enrolled
4 Trials studying Obsessive-Compulsive Disorder
291 Patients Enrolled for Obsessive-Compulsive Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of people participating in this medical trial?

"This particular medical trial is not actively recruiting patients. It was initially posted on October 10th 2018 and the listing was last updated November 1st 2022. If you are seeking alternative clinical trials, there are presently 114 different studies searching for OCD sufferers and 7 experiments that require participants to test this treatment."

Answered by AI

Does this experiment have an age limit, and if so, does it extend beyond fifty years?

"To be eligible for this medical study, participants must fall under the age of 50 and exceed 18 years old."

Answered by AI

Is this treatment a novel approach, or has it been studied before?

"Presently, there are 7 ongoing trials for this specific intervention with none in the third phase. Although Cape Town and New york have a large number of studies being conducted for it, 25 other medical centres around the world are involved as well."

Answered by AI

Are there still opportunities for participants to join this clinical research?

"The medical trial in question is not actively seeking participants at this current time. The study was first posted on October 10th 2018 and the last update was November 1st 2022, but there are still 121 other studies enrolling patients right now."

Answered by AI

Is this approach to treatment efficacious and innocuous for individuals?

"This treatment is approved for use, so the safety score assigned by our Power team was a 3."

Answered by AI

Would I be able to join this clinical experiment?

"This clinical trial, which hopes to recruit 250 participants in total, requires that those wishing to participate have an OCD diagnosis and are within the 18-50 year old age bracket."

Answered by AI
Recent research and studies
~39 spots leftby Mar 2025